BNTC - Benitec Biopharma - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

71.74M

Cash

14.14M

Avg Qtr Burn

-5.051M

Short % of Float

1.38%

Insider Ownership

9.28%

Institutional Own.

65.77%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
BB-301 Details Oculopharyngeal Muscular Dystrophy	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.